RF Lifting Wand Australia: TGA ARTG Registration, RCM Compliance, and the Documentation Path for Korean Exporters

To sell an RF lifting wand in Australia, a Korean exporter must clear two parallel regulatory tracks: TGA ARTG inclusion as a Class IIa active medical device, and RCM/ACMA certification for the device's Bluetooth and electrical components. Korean manufacturers already holding CE certification under EU MDR can use it as Manufacturer's Evidence with TGA, cutting the total compliance timeline to approximately 2–4 months. This guide covers every document required—from the Korean factory through to Australian customs clearance—including the KAFTA paperwork that can qualify the shipment for preferential tariff rates.

Why Australia Has Two Compliance Tracks

Australia treats your RF lifting wand as two different products at the same time. As a device that delivers radiofrequency energy to the body for therapeutic purposes, it is a medical device governed by the Therapeutic Goods Administration (TGA). As a Bluetooth-connected consumer electronic with a rechargeable lithium-ion battery and wireless module, it falls under the Australian Communications and Media Authority (ACMA).

Both regulators must clear the product before it can be legally supplied in Australia. Missing either track means the Australian Border Force can seize the shipment at the port of entry under Section 71A of the Customs Act, per the Australian Border Force (ABF). Planning both compliance programs in parallel—not sequentially—is the practical way to avoid adding months to your market entry schedule.

Track 1 — TGA ARTG Registration

Classification: Active Medical Device, Class IIa

Per the Therapeutic Goods Administration (TGA), active medical devices that supply energy to the patient's body are classified as Class IIa under the Therapeutic Goods (Medical Devices) Regulations 2002. A 1 MHz radiofrequency wand that heats dermal tissue to stimulate collagen production falls into this class. The TGA's ARTG public summary confirms that radiofrequency skin surface treatment systems can achieve ARTG inclusion—ARTG entry 378242 lists exactly this type of device registered under TGA regulations.

Per Elexes (citing TGA January 2026 guidance), the TGA clarified in January 2026 that importation is triggered when a device enters Australia for supply, not merely for transit or storage. From that point, full sponsor-level compliance obligations apply immediately.

The Australian Sponsor Requirement

Korean manufacturers cannot apply for ARTG inclusion directly. Per Artixio (citing TGA Therapeutic Goods Act 1989 requirements), the Korean manufacturer must appoint an Australian Sponsor—a legally established Australian entity with a physical address. The Sponsor's name and contact details must appear on the device label and in every ARTG database entry. Without a registered Australian Sponsor, the ARTG application cannot proceed.

Under Australian law, the Australian importer takes on full legal liability for device safety, compliance, and any injury or malfunction, per the Australian Beauty Association. This shapes every contract and indemnity arrangement negotiated with an Australian distribution partner.

Using CE Mark as the Fast Route to ARTG Inclusion

If the RF wand already holds CE certification under EU MDR—specifically an MDR Annex IX QMS certificate and a product design or type examination certificate from an EU Notified Body—TGA accepts it as Manufacturer's Evidence under the Therapeutic Goods (Overseas Regulators) Determination 2018. This is the most practical pathway for Korean devices already CE-certified.

Per MedEnvoy Global, TGA's target processing time for Manufacturer's Evidence applications is 15 working days, with no separate ME submission fee. The full CE-mark abridged route end-to-end typically takes 2–4 months. A full TGA conformity assessment built from scratch takes 18–24 months by comparison.

Annual ARTG maintenance fees for Class IIa devices are AUD 1,095 per year, per Artixio (citing TGA fee schedule). After initial ARTG inclusion, build this cost into the Australian partner's annual operating budget.

Essential Principles Checklist and IEC Standards

Every ARTG application must include a completed Essential Principles Checklist, per the Therapeutic Goods Administration (TGA). This document maps each safety and performance requirement—electrical safety, electromagnetic compatibility, biocompatibility, labeling, and clinical evidence—to the manufacturer's specific test reports, risk files, and clinical data. Gaps in this checklist pause the ARTG application clock.

Per KD&A Consulting (citing TGA guidance for active medical devices, August 2023), active medical devices in Australia must comply with IEC 60601-1 (general safety of medical electrical equipment) and IEC 60601-1-2 (electromagnetic compatibility). Even battery-powered RF devices require an EMC risk analysis under IEC 60601-1-2 clauses 7–8, and compatibility information must appear in the Instructions For Use.

New UDI Requirement (Effective March 2025)

Per RegDesk (citing TGA UDI implementation guidance), the TGA's Unique Device Identification (UDI) framework took effect on 24 March 2025. All new ARTG applications filed in 2026 and beyond must address UDI requirements, including compliant device identifiers on the device label and in the ARTG database entry. Plan UDI implementation before the application is lodged—it is not a step that can be added after submission.

Track 2 — RCM/ACMA Certification

The Regulatory Compliance Mark (RCM) is mandatory for all electrical and electronic equipment sold in Australia and New Zealand, including wireless devices with Bluetooth connectivity, per MiCOM Labs. The RF wand's Bluetooth 5.0 module, USB-C charging circuit, and lithium-ion battery all fall within RCM scope.

Who Can Sign the Supplier's Declaration of Conformity

Korean exporters face a key restriction: foreign manufacturers cannot independently sign the Supplier's Declaration of Conformity (SDoC), per MiCOM Labs. Only an Australian legal entity—the importer or an authorized representative with a physical street address, not a P.O. box—may sign the SDoC. The Korean factory provides the technical documentation; the Australian entity signs and takes accountability.

Updated ACMA Standards from January 2025

Per Access Communications, two mandatory ACMA standards changed from 1 January 2025:

• AS/NZS CISPR 32:2023 replaces the older multimedia equipment EMC standard
• AS/NZS 62368-1 replaces AS/NZS 60950-1 for IT and audio/video equipment

Certificates issued under the previous standards expired on 31 December 2025. If any existing test reports reference the superseded standards, new accredited laboratory testing is required before the device can be supplied in Australia.

The Radiocommunications (Low Interference Potential Devices) Class Licence 2025 also applies to the device's Bluetooth 5.0 module, per Access Communications (citing the ACMA Radiocommunications framework). Confirm Bluetooth test reports comply with the 2025 framework before the SDoC is signed.

RCM Compliance Timeline

Per MiCOM Labs, full RCM compliance—pre-compliance testing, accredited laboratory testing, and SDoC preparation—takes 4–7 weeks from project start, assuming first-pass test results. ACMA requires compliance records, test reports, certificates, and technical documentation to be kept for up to 10 years and available for inspection at any time.

Run TGA ARTG and RCM compliance programs in parallel. Both can begin once the Korean factory's technical documentation package is assembled, and neither needs to wait for the other to complete first.

The Bluetooth App — A Third Registration to Plan For

The RF wand pairs with a mobile app via Bluetooth 5.0 for skin analysis and personalized care routine recommendations. Per KD&A Consulting (citing TGA guidance for active medical devices, August 2023), software paired with a medical device—including Bluetooth-connected apps that perform skin analysis—may require its own separate ARTG registration as Software as a Medical Device (SaMD).

SaMD compliance would require IEC 62304 (software lifecycle processes) and IEC 62366 (usability engineering). The app's version number must be identifiable to users at all times. Determine whether the app's specific intended purpose triggers SaMD requirements before the hardware ARTG application is filed. Addressing this question early is significantly simpler than handling it after the hardware submission is underway.

Documentation Path: Korean Factory to Australian Customs

The complete path from manufacturing sign-off in Korea to legal supply in Australia involves ten distinct actions across three regulatory tracks. Steps 1–5 cover the TGA ARTG track. Steps 6–7 cover RCM/ACMA. Steps 8–10 cover trade and customs documentation. All three tracks should progress in parallel where possible to compress the overall timeline.

Timelines and Fees at a Glance

For Korean exporters with existing CE certification, the CE-mark route reduces the ARTG timeline substantially compared to a full TGA conformity assessment from scratch. RCM/ACMA compliance runs in parallel under either pathway and does not affect which TGA route is chosen.

KAFTA Tariff Advantage and Customs Clearance

Under the Korea–Australia Free Trade Agreement (KAFTA), effective 12 December 2014, 99.7% of Australian imports from Korea were covered by preferential tariff rates by 2022, per the Australian Government Department of Foreign Affairs and Trade (DFAT). Korean-made electronics—including HS code 8543.70 devices—fall within this broad coverage.

To claim the preferential tariff rate at Australian customs, the Korean exporter must obtain a KAFTA Certificate of Origin and present it with the shipment at customs, per DFAT. Without this certificate, the Australian importer pays standard duty rates on the shipment.

Commercial imports of medical devices into Australia also require lodging an Import Declaration (Form B650) with the Australian Border Force under Section 71A of the Customs Act, per the Australian Border Force (ABF). The ARTG number must be included in the import declaration. Medical devices without ARTG inclusion or a registered Australian Sponsor may be seized at the Australian border.

Key Documents at a Glance

The checklist below covers all documents required from the Korean factory through to Australian customs clearance, including both the TGA ARTG track and the RCM/ACMA track. Each item has a mandatory role in one or more regulatory approvals.

Frequently Asked Questions

The questions below address what sourcing managers and importers ask most when evaluating an RF lifting wand from a Korean manufacturer for the first time.

Does a home-use RF lifting wand need TGA ARTG registration to be legally sold in Australia?

Yes. Per Elexes (citing TGA January 2026 guidance), all medical devices imported for supply in Australia must be included in the ARTG before they can be legally supplied. The TGA clarified in January 2026 that importation is triggered when a device enters Australia for supply — activating full sponsor-level obligations immediately. An RF lifting wand that delivers 1 MHz radiofrequency energy to the dermis is classified as a Class IIa active medical device under the Therapeutic Goods (Medical Devices) Regulations 2002. Without ARTG inclusion and a registered Australian Sponsor, the Australian Border Force can seize the shipment at port of entry, per the Australian Border Force (ABF).

Can a Korean manufacturer use their existing CE mark instead of a full TGA conformity assessment?

Yes, CE certification under EU MDR is the fastest path to ARTG inclusion. Per MedEnvoy Global, a CE certificate combining an MDR Annex IX QMS certificate with a product design or type examination certificate qualifies as Manufacturer's Evidence under the Therapeutic Goods (Overseas Regulators) Determination 2018. TGA's target processing time for Manufacturer's Evidence applications is 15 working days, with no separate submission fee. The full CE-mark abridged route end-to-end typically takes 2–4 months, compared to 18–24 months for a full TGA conformity assessment built from scratch. Confirm the CE certificates are current and reference the correct MDR Annex before the Australian Sponsor files the application.

Does the Bluetooth 5.0 RF wand need separate RCM/ACMA approval in addition to TGA ARTG registration?

Yes — the two tracks are fully independent and both are required. Per MiCOM Labs, the RCM is mandatory for all electrical and electronic equipment sold in Australia and New Zealand, including wireless devices with Bluetooth connectivity. TGA ARTG covers the device's therapeutic function. ACMA via the RCM covers electromagnetic emissions, electrical safety, and wireless spectrum compliance. From 1 January 2025, updated mandatory ACMA standards apply: AS/NZS CISPR 32:2023 and AS/NZS 62368-1 replaced the older standards, and certificates under the previous versions expired 31 December 2025. The Bluetooth 5.0 module must also comply with the ACMA Radiocommunications Class Licence 2025, per Access Communications.

Does the companion mobile app for the RF device need its own ARTG registration in Australia?

It may. Per KD&A Consulting (citing TGA guidance for active medical devices, August 2023), software embedded in or paired with a medical device — including Bluetooth-connected apps that perform skin analysis or recommend care routines — may require its own separate ARTG registration as Software as a Medical Device (SaMD). SaMD compliance requires IEC 62304 (software lifecycle processes) and IEC 62366 (usability engineering). The app version number must be identifiable to users at all times. Confirm whether the app's specific intended purpose triggers SaMD requirements with your Australian Sponsor and a TGA regulatory consultant before the hardware ARTG application is filed.

Does the Korea–Australia Free Trade Agreement reduce import duties on Korean RF beauty devices, and what paperwork is required?

Under KAFTA, effective 12 December 2014, 99.7% of Australian imports from Korea were covered by preferential tariff rates by 2022, per the Australian Government Department of Foreign Affairs and Trade (DFAT). Korean-made electronics including HS code 8543.70 devices fall within this broad coverage. To claim the preferential duty rate, the Korean exporter must obtain a KAFTA Certificate of Origin and present it with the shipment to Australian customs, per DFAT. Without this certificate, the Australian importer pays standard duty rates. Commercial medical device imports also require lodging an ABF Import Declaration (Form B650) under Section 71A of the Customs Act, with the ARTG number included.

Ready to Export Your Korean RF Lifting Wand to Australia?

Selling a Korean RF lifting wand in Australia requires TGA ARTG registration as a Class IIa medical device, RCM/ACMA certification for the Bluetooth and electrical components, and a complete set of customs documents filed before the shipment reaches the Australian border. Korean manufacturers already holding CE certification under EU MDR can use the 2–4 month Manufacturer's Evidence pathway, which cuts years off the traditional TGA timeline.

Running all three compliance tracks—TGA, ACMA/RCM, and trade documentation—in parallel is what keeps your market entry schedule on track. As a Korean trade platform, we connect RF device exporters with CE-certified Korean manufacturers, help verify compliance documentation before the ARTG application is filed, and coordinate customs paperwork for smooth Australian port clearance.

This information is provided for reference only. TGA regulations, ACMA standards, and ABF customs procedures change over time. Always confirm current obligations directly with the Therapeutic Goods Administration, the Australian Communications and Media Authority, the Australian Border Force, and a licensed regulatory consultant before acting on this information.